Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival
Body Mass Index
Fatty Acid Synthases
Polymorphism, Single Nucleotide
FASN germline polymorphisms were significantly associated with risk of lethal PCa. Significant interactions of BMI with FASN polymorphisms and FASN tumor expression suggest FASN as a potential link between obesity and poor PCa outcome and raise the possibility that FASN inhibition could reduce PCa-specific mortality, particularly in overweight men.